Oncotarget
Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases.The term was introduced in the inaugural Editorial,Introducing Oncotarget.
As of January 1, 2022,Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
SSP 47th Annual Meeting
Post-Publication Promotion
Learn about ourFREE
Impact Journals, LLC is the publisher of Oncotarget:www.impactjournals.com.
Impact Journals is a member of theWellcome Trust List of Compliant Publishers.
Impact Journals is a member of theSociety for Scholarly Publishing.
On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control.This malicious action will be reported to the FBI.
Current Volume
This Month's Popular DOIs
(Crossref resolutions)
| 10.18632/ONCOTARGET.6429 |
| 10.18632/ONCOTARGET.5435 |
| 10.18632/ONCOTARGET.19087 |
| 10.18632/ONCOTARGET.9859 |
| 10.18632/ONCOTARGET.23208 |
Most popular Oncotarget DOIs, measured by the number of times each DOI was successfully resolved.
Most Popular DOIs Published in 2024
(Crossref Data)
Most Popular DOIs of 2024
(Crossref Data)
Milestones in Modern Scholarly Publishing
On August 25, 2022, the Office of Science and Technology Policy announced a new government policy legislating the immediate public release of all United States-funded research publications by 2025.Learn more here.
On May 23, 2023, the Council of the European Union adopted conclusions on high-quality, transparent, open, trustworthy, and equitable scholarly publishing. The Council calls for immediate and unrestricted open access to publishing research involving public funds.Learn more.
Oncotarget.org: Blog Posts on
New & Trending Papers
Oncotarget.net: Latest Insights
From Our Authors
June 25, 2019
About The Cover
The cover for issue 41 of Oncotarget features Figure 1, "Patient enrolment by region," byMalik, et al.
Table of Contents
Editorial
| Transmissible ER stress shapes the leukemic microenvironment |
https://doi.org/10.18632/oncotarget.27012 John T. Butler, and Peter Kurre |
| 4080-4082 |
| PDF | How to cite |
Research Papers
| Palmitate up-regulates laminin expression via ROS/integrin αvβ3 pathway in HLSECs |
https://doi.org/10.18632/oncotarget.26937 Qi Zhang,Luxia Jiang,Jing Yu,Limin Tian,Tiankang Guo,Baoshan Di,Jinxing Quan,Jing Feng, and Jing Liu |
| 4083-4090 |
| Abstract | PDF | Full Text | How to cite |
| The heterogeneity and complexity ofCannabis extracts as antitumor agents |
https://doi.org/10.18632/oncotarget.26983 Liran Baram,Ella Peled,Paula Berman,Ben Yellin,Elazar Besser,Maya Benami,Igal Louria-Hayon,Gil M. Lewitus, and David Meiri |
| 4091-4106 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
| GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer |
https://doi.org/10.18632/oncotarget.26993 Avaniyapuram Kannan Murugan,Ebtesam Qasem,Hindi Al-Hindi, and Ali S. Alzahrani |
| 4107-4124 |
| Abstract | PDF | Full Text | How to cite |
| Transcriptional suppression of the miR-15/16 family by c-Myc in malignant pleural mesothelioma |
https://doi.org/10.18632/oncotarget.27010 Marissa Williams,Yuen Yee Cheng,Michaela B. Kirschner,Kadir H. Sarun,Karin Schelch,Patrick Winata,Brian McCaughan,Steven Kao,Nico Van Zandwijk, and Glen Reid |
| 4125-4138 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
| Genomic characterization of early-stage esophageal squamous cell carcinoma in a Japanese population |
https://doi.org/10.18632/oncotarget.27014 Yuji Urabe,Kenichi Kagemoto,C. Nelson Hayes,Koki Nakamura,Kazuhiko Masuda,Atsushi Ono,Shinji Tanaka,Koji Arihiro, and Kazuaki Chayama |
| 4139-4148 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
| Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging |
https://doi.org/10.18632/oncotarget.27024 Yuri Tolkach,Diane Goltz,Anika Kremer,Hojjat Ahmadzadehfar,Dominik Bergheim,Markus Essler,Marnix Lam,Bart de Keizer,Hans-Peter Fischer, and Glen Kristiansen |
| 4149-4160 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
| Real-world experience with cabazitaxel in patients with metastatic castration-resistant prostate cancer: a final, pooled analysis of the compassionate use programme and early access programme |
https://doi.org/10.18632/oncotarget.27031 Zafar Malik,Axel Heidenreich,Sergio Bracarda,Alexandros Ardavanis,Philip Parente,Hans-Joerg Scholz,Ayse Ozatilgan,Evelyne Ecstein-Fraisse,Simon Hitier, and Giuseppe Di Lorenzo |
| 4161-4168 |
| Abstract | PDF | Full Text | How to cite |
| SPARC gene deletion protects against toxic liver injury and is associated to an enhanced proliferative capacity and reduced oxidative stress response |
https://doi.org/10.18632/oncotarget.9456 Estanislao Peixoto,Catalina Atorrasagasti,Mariana Malvicini,Esteban Fiore,Marcelo Rodriguez,Mariana Garcia,Paola Finocchieto,Juan J. Poderoso,Fernando Corrales, and Guillermo Mazzolini |
| 4169-4179 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
| Cryoablation inhibition of distant untreated tumors (abscopal effect) is immune mediated |
https://doi.org/10.18632/oncotarget.24105 Xueling Yang,Yongfei Guo,Zhi Guo,Tongguo Si,Wenge Xing,Wenwen Yu, and Yan Wang |
| 4180-4191 |
| Abstract | PDF | Full Text | How to cite |
| MicroRNA-873 inhibits colorectal cancer metastasis by targeting ELK1 and STRN4 |
https://doi.org/10.18632/oncotarget.24115 Chuannan Fan,Biyu Lin,Zhengjie Huang,Dan Cui,Minyi Zhu,Zhenling Ma,Yunda Zhang,Fan Liu, and Yingfu Liu |
| 4192-4204 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
Meta-Analysis
| Risk of venous and arterial thromboembolic events associated with tyrosine kinase inhibitors in advanced thyroid cancer: a meta-analysis and systematic review |
https://doi.org/10.18632/oncotarget.24599 Yang Bai,Jing-Yan Li,Jie Li,Bo Zhang,Yong-Hong Liu,Bu-Yong Zhang, and Jian Jing |
| 4205-4212 |
| Abstract | PDF | Full Text | How to cite |
Clinical Research Papers
| Detecting predictive androgen receptor modifications in circulating prostate cancer cells |
https://doi.org/10.18632/oncotarget.3925 Julie Steinestel,Manuel Luedeke,Annette Arndt,Thomas J. Schnoeller,Jochen K. Lennerz,Carina Wurm,Christiane Maier,Marcus V. Cronauer,Konrad Steinestel, and Andres J. Schrader |
| 4213-4223 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
Reviews
| Constructing personalized longitudinal holo’omes of colon cancer-prone humans and their modeling in flies and mice |
https://doi.org/10.18632/oncotarget.6463 Myrofora Panagi,Konstantina Georgila,Aristides G. Eliopoulos, and Yiorgos Apidianakis |
| 4224-4246 |
| Abstract | PDF | Full Text | How to cite |
Corrections
| Erratum: CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities |
https://doi.org/10.18632/oncotarget.27038 Stéphane Terry,Ihsan Y. El-Sayed,Damien Destouches,Pascale Maillé,Nathalie Nicolaiew,Guillaume Ploussard,Fannie Semprez,Cynthia Pimpie,Himisha Beltran,Arturo Londono-Vallejo,Yves Allory,Alexandre de la Taille,David S. Salomon, and Francis Vacherot |
| 4247-4248 |
| Correction | PDF | How to cite |
| Correction: Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents |
https://doi.org/10.18632/oncotarget.27042 Julie Gaston,Laura Cheradame,Vanessa Yvonnet,Olivier Deas,Marie-France Poupon,Jean-Gabriel Judde,Stefano Cairo, and Vincent Goffin |
| 4249-4251 |
| Correction | PDF | How to cite |
Retraction
| Retraction: Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway |
https://doi.org/10.18632/oncotarget.27064 Xin-Shuang Yu,Juan Du,Yu-Jun Fan,Feng-Jun Liu,Li-Li Cao,Ning Liang,De-Guo Xu, and Jian-Dong Zhang |
| 4252-4252 |
| Retraction | PDF | How to cite |
Copyright © 2025 Rapamycin Press LLC dba Impact Journals